Truist Financial Cuts National Health Investors (NYSE:NHI) Price Target to $81.00

National Health Investors (NYSE:NHI) had its price objective decreased by analysts at Truist Financial from $89.00 to $81.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the real estate investment trust’s stock. Truist Financial’s price target indicates a potential upside of 12.20% from the company’s current price.

Other research analysts also recently issued research reports about the stock. Weiss Ratings restated a “buy (b)” rating on shares of National Health Investors in a report on Friday, March 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a research report on Wednesday, April 22nd. Finally, Wells Fargo & Company lowered their price objective on National Health Investors from $84.00 to $79.00 and set an “equal weight” rating on the stock in a report on Monday, June 1st. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $85.33.

National Health Investors Stock Up 0.3%

Shares of NYSE NHI traded up $0.23 during trading hours on Friday, hitting $72.19. The stock had a trading volume of 10,799 shares, compared to its average volume of 342,343. The firm’s 50-day moving average price is $77.48 and its two-hundred day moving average price is $80.14. National Health Investors has a 52 week low of $67.94 and a 52 week high of $91.38. The company has a market capitalization of $3.50 billion, a P/E ratio of 23.30, a P/E/G ratio of 3.79 and a beta of 0.52. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.39). The business had revenue of $115.13 million for the quarter, compared to the consensus estimate of $70.22 million. National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. National Health Investors’s revenue was up 28.9% compared to the same quarter last year. During the same period in the previous year, the business posted $1.15 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Analysts anticipate that National Health Investors will post 5.07 EPS for the current fiscal year.

Insider Activity

In other news, CEO D. Eric Mendelsohn bought 1,500 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The stock was acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares of the company’s stock, valued at $9,177,473.44. This trade represents a 1.14% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.70% of the company’s stock.

Institutional Trading of National Health Investors

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NHI. International Assets Investment Management LLC acquired a new position in shares of National Health Investors in the 4th quarter worth approximately $27,000. EverSource Wealth Advisors LLC boosted its stake in shares of National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new stake in shares of National Health Investors in the 4th quarter worth about $33,000. GAMMA Investing LLC increased its position in shares of National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 136 shares in the last quarter. Finally, Key Capital Management INC acquired a new position in National Health Investors in the fourth quarter valued at about $47,000. Institutional investors own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.